90. Influenza Other Respir Viruses. 2024 Oct1810e13314. doi 10.1111irv.13314. Meeting Report From Correlates of Protection for Next Generation Influenza Vaccines Lessons Learned From the COVID19 Pandemic. Krammer F1234, Katz JM5, Engelhardt OG6, Post DJ7, Roberts PC7, Sullivan SG89, Tompkins SM101112, Chiu C13, SchultzCherry S14, Cox RJ1516. Author information 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 2Center for Vaccine Research and Pandemic Preparedness CVaRPP, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 3Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 4Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria. 5The Task Force for Global Health, Decatur, Georgia, USA. 6Science Research Innovation, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK. 7Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health DMIDNIAIDNIH, Rockville, Maryland, USA. 8WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, and Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. 9Department of Epidemiology, University of California, Los Angeles, Los Angeles, California, USA. 10Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA. 11Center for Influenza Disease and Emergence Response CIDER, University of Georgia, Athens, Georgia, USA. 12Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA. 13Department of Infectious Diseases, Imperial College London, London, UK. 14Department of HostMicrobe Interactions, St Jude Childrens Research Hospital, Memphis, Tennessee, USA. 15Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.